Big Data for Big Pharma
Sofort verfügbar, Lieferzeit: 1-3 Tage
5,15 €
14 Tage Zufriedenheitsgarantie
Risikofrei bestellen
Geprüfte Gebrauchtware
Einzeln geprüft
Produktinformationen "Big Data for Big Pharma"
Raising costs, ever-increasing regulatory hurdles, and mounting difficulties in finding the next blockbuster drug are just a few of the challenges Big Pharma currently has to face for its research and development process, the heart of its risky business. Big Data claims to be full of insights that Big Pharma need to find a way of harvesting, which could lead to new compounds. Academics, Big Data start-ups, and pharmaceutical companies have focused their research efforts on analytic tools and data technologies to store, collect, analyse, and extract these insights from massive data sets. However, the key question is whether the Big Data hype really does have the claimed accelerating effect on the complex research and development process or if it actually creates another hurdle for Big Pharma innovation. Malena Johannes' timely book sheds light on this question by examining the top 5 pharmaceutical companies and provides an overview on the status quo of Big Data applications within the pharmaceutical industry.
| H | B | T | Gramm | 210 mm | 148 mm | 8 mm | 179 gr |
| Erscheinungsjahr | 2016 |
| FSK | 0 |
| Ausgabe | Taschenbuch |
| Publisher | Books on Demand GmbH, In de Tarpen 42, 22848, Norderstedt, 040 53433511, 040 53433584, info@bod.de |
| ISBN-10 | 3838209427 |
| ISBN-13 | 9783838209425 |
| Autor | Malena Johannes |
| Sprache | Englisch |
Anmelden
Wusstest du, dass...
ein wiederverkauftes Buch rund 2,7 kg CO₂ einspart – das entspricht einer 14 km langen Autofahrt?
Erfahre mehr zum Thema Nachhaltigkeit bei BuchparkVersandkostenfrei ab 19 €
14 Tage Rückgaberecht - Kein Risiko
Geprüfte Gebrauchtware